01 1AARTI DRUGS LTD
02 1Aurobindo Pharma Limited
03 1Cadila Pharmaceuticals Limited
04 1Cambrex Profarmaco Milano Srl
05 1Cipla Ltd.
06 1Eli Lilly Kinsale Limited
07 1Erregierre SpA
08 1Glochem Industries Private Limited
09 1Hetero Drugs Limited
10 1Olon S.p.A.
11 1Sicor S.r.l.
12 1Srini Pharmaceuticals Private Limited
01 1RALOXIFENE HYDROCHLORIDE
02 1Raloxifene HCl
03 7Raloxifene Hydrochloride
04 2Raloxifene hydrochloride
05 1Raloxifene-Hydrochloride
01 7India
02 3Italy
03 2U.S.A
NDC Package Code : 62704-0115
Start Marketing Date : 1998-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65862-714
Start Marketing Date : 2024-01-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65691-0079
Start Marketing Date : 2013-05-06
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 12828-0085
Start Marketing Date : 2011-01-03
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 53104-7652
Start Marketing Date : 2016-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 63419-0420
Start Marketing Date : 2008-10-30
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 49706-1723
Start Marketing Date : 2010-01-08
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 24234-0008
Start Marketing Date : 2023-11-21
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 17337-0071
Start Marketing Date : 2019-08-27
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 53183-4005
Start Marketing Date : 2010-09-13
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Evista manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Evista, including repackagers and relabelers. The FDA regulates Evista manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Evista API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Evista manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Evista supplier is an individual or a company that provides Evista active pharmaceutical ingredient (API) or Evista finished formulations upon request. The Evista suppliers may include Evista API manufacturers, exporters, distributors and traders.
click here to find a list of Evista suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Evista as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Evista API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Evista as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Evista and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Evista NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Evista suppliers with NDC on PharmaCompass.
We have 12 companies offering Evista
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
